Blood markers for stroke severity and recovery
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at whether certain blood markers (white blood cell types compared to albumin) can predict how severe a stroke is and how well a person will recover. It may help doctors better understand stroke outcomes, but eligibility is very strict.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your stroke must be the ischemic type (caused by a blocked blood vessel) and confirmed by brain scan (CT or MRI).
- You must arrive at the hospital within 48 hours of when stroke symptoms started.
- You must not have had a previous ischemic stroke or received clot-busting treatment (IV tPA) or clot-removal procedure (mechanical thrombectomy) for this episode.
- You must not have conditions that affect your blood cells or albumin levels, such as autoimmune diseases, active infections, severe liver or kidney disease, blood disorders, cancer, or current use of immunosuppressants or steroids.
- You must have blood drawn for a complete blood count and albumin level at admission, and consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood and clot samples from people who have had a stroke to understand how inflammatory cells behave. It may help doctors learn more about why strokes happen and improve treatments in the future.
This study looks at blood tests to find signs of immune activity after a suspected stroke. It may help doctors diagnose stroke faster and better understand what is happening in the body soon after symptoms start.
This study looks at two proteins in the blood that may be linked to brain swelling after a bleeding stroke (intracerebral hemorrhage). It aims to understand how the body's immune response affects recovery, which could lead to better treatments.
This study looks at whether blood tests taken after your first stroke can help predict if you might have memory or thinking problems early on. It focuses on people with a stroke in the basal ganglia area of the brain, with the goal of identifying those who may need extra support sooner.
This trial looks at blood “inflammation-related” biomarkers to understand what happens early after certain sudden brain events. It may help doctors predict outcomes and tailor treatment for people like those with stroke types that sometimes need a clot-removal procedure.
This study looks at how certain proteins in the blood change after a procedure to remove a large blockage in a brain artery. The goal is to better understand recovery after stroke treatment.
Hear when a new Acute Ischemic Stroke (AIS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.